Choose from one of the exhibit options below and reserve a space by February 21, 2025.
$2,450 exhibit fee includes:
$4,900 exhibit fee includes:
Additional registrations are available to industry exhibitors for $400 each.
Please note:
Please contact Dana McClure, Meetings and Exhibits Coordinator, at dmcclure@facs.org or 312-202-5332 for more information
(The 2025 exhibit schedule will be shared when the program is finalized)
Exhibit Setup* | 6:00–7:00 am
Exhibit Hours | 7:00 am–6:30 pm
Exhibit Tear Down** | 6:30–9:00 pm
*Exhibits must be staffed during exhibit hours. Any space not occupied by 8:00 am on Wednesday, March 19, 2025, will be forfeited by the exhibitor.
**Displays may not be dismantled or any packaging begun before 6:00 pm on Wednesday, March 19, 2025.
In case of cancelation of the ACS Surgeons and Engineers meeting due to high risk of COVID-19 exposure, exhibitors will receive all exhibit space fees paid to ACS Surgeons and Engineers. ACS Surgeons and Engineers is not responsible for any fees paid to third parties.
Exhibitors are responsible for keeping their space sanitized. ACS Surgeons and Engineers will be responsible for sanitizing general areas of the exhibit hall and meeting space.
Written notification of a space cancelation must be received by ACS on or before February 14, 2025 to be eligible for a refund. A $500 service charge will be assessed for each canceled space. No refunds will be given after February 9, 2025.
In the event the exhibition is canceled, postponed, or relocated on account of fire, strikes, government regulations, casualties, Acts of God, or other causes beyond the control of ACS, the exhibitor waives any and all damages and claim for damages and agrees that the sole liability of ACS shall be to return each exhibitors the exhibitors's rental payment
Exhibitors must abide by all applicable Food and Drug Administration (FDA) regulations, including but not limited to any or all approved requirements. Exhibitors are reminded that the FDA prohibits the advertising or other promotion of investigational or unapproved drugs and devices and forbids the promotion of approved drugs or devices for unapproved uses. For additional infirmation, contact the FDA at 888-463-6332 or visit fda.gov.